This inventor holds 2 USPTO granted patents. Top assignee: Laimu Corporation. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Takeru Koga: Innovator in Neurogenesis and Nerve Growth Promotion
Introduction
Takeru Koga is a prominent inventor based in Shobara, Japan. He has made significant contributions to the field of neurogenesis and nerve growth promotion. With a total of 2 patents, Koga's work focuses on developing innovative solutions that enhance the differentiation of stem cells into nerve cells.
Latest Patents
Koga's latest patents include a neurogenesis stimulant and a nerve growth promoter. The neurogenesis stimulant is designed as an internal agent and culture medium additive, which contains a compound with a specific structure. This compound features an alkyl group with 1 to 10 carbon atoms, and its design allows for the presence or absence of a bond. The nerve growth promoter contains valine, where the hydrogen atom of the amino group can be substituted with a substituent. This invention is notable for its high effectiveness in promoting the differentiation of stem cells into nerve cells and the formation of neurites in nerve cells. Additionally, the active ingredient in this promoter is resistant to degradation by digestive enzymes.
Career Highlights
Koga is currently associated with Laimu Corporation, where he continues to push the boundaries of innovation in his field. His work has garnered attention for its potential applications in regenerative medicine and neurobiology.
Collaborations
Koga collaborates with notable colleagues, including Sachio Wakayama and Akihiro Tai, who contribute to his research endeavors.
Conclusion
Takeru Koga's innovative work in neurogenesis and nerve growth promotion highlights his significant role in advancing medical science. His patents reflect a commitment to developing effective solutions for nerve cell differentiation and regeneration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile